These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17721076)

  • 21. Prospects for p53-based cancer therapy.
    Stokłosa T; Gołab J
    Acta Biochim Pol; 2005; 52(2):321-8. PubMed ID: 15990917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of p53 in cancer drug resistance and targeted chemotherapy.
    Hientz K; Mohr A; Bhakta-Guha D; Efferth T
    Oncotarget; 2017 Jan; 8(5):8921-8946. PubMed ID: 27888811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical induced alterations in p53 signaling.
    Högberg J; Silins I; Stenius U
    EXS; 2009; 99():181-208. PubMed ID: 19157062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 rescue and modulation of p53 redox state.
    Bykov VJ; Lambert JM; Hainaut P; Wiman KG
    Cell Cycle; 2009 Aug; 8(16):2509-17. PubMed ID: 19633417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 family members in cancer diagnosis and treatment.
    Machado-Silva A; Perrier S; Bourdon JC
    Semin Cancer Biol; 2010 Feb; 20(1):57-62. PubMed ID: 20206267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From tumor prevention to therapy: empowering p53 to fight back.
    Frezza C; Martins CP
    Drug Resist Updat; 2012 Oct; 15(5-6):258-67. PubMed ID: 23164556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.
    Pfister NT; Prives C
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27836911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the p53-MDM2 pathway.
    Åberg E; Saccoccia F; Grabherr M; Ore WYJ; Jemth P; Hultqvist G
    BMC Evol Biol; 2017 Aug; 17(1):177. PubMed ID: 28774266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of p53 by specific agents in potential cancer therapy.
    Ho JW; Song JZ; Leung YK
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):131-5. PubMed ID: 15777220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
    Blandino G; Di Agostino S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discovery and mutant p53.
    Maslon MM; Hupp TR
    Trends Cell Biol; 2010 Sep; 20(9):542-55. PubMed ID: 20656489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological reactivation of p53 as a strategy to treat cancer.
    Zawacka-Pankau J; Selivanova G
    J Intern Med; 2015 Feb; 277(2):248-259. PubMed ID: 25495071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring p53 function in cancer: novel therapeutic approaches for applying the brakes to tumorigenesis.
    Di Cintio A; Di Gennaro E; Budillon A
    Recent Pat Anticancer Drug Discov; 2010 Jan; 5(1):1-13. PubMed ID: 19663772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 as a target for the treatment of cancer.
    Duffy MJ; Synnott NC; McGowan PM; Crown J; O'Connor D; Gallagher WM
    Cancer Treat Rev; 2014 Dec; 40(10):1153-60. PubMed ID: 25455730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Enigma of p53.
    Lozano G
    Cold Spring Harb Symp Quant Biol; 2016; 81():37-40. PubMed ID: 27932563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.